Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation
Yi Li, Haitao Li, Shuai Liu, et al.
Molecular Immunology (2018) Vol. 99, pp. 134-144
Closed Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George, Athol U. Wells, Gisli Jenkins
The Lancet Respiratory Medicine (2020) Vol. 8, Iss. 8, pp. 807-815
Open Access | Times Cited: 985
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Benjamin J. Moss, Stefan W. Ryter, Iván O. Rosas
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 515-546
Closed Access | Times Cited: 419
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
Saleela M. Ruwanpura, Belinda J. Thomas, Philip G. Bardin
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 62, Iss. 4, pp. 413-422
Closed Access | Times Cited: 194
lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis
Yanni Yang, Wenlin Tai, Nihong Lu, et al.
Aging (2020) Vol. 12, Iss. 10, pp. 9085-9102
Open Access | Times Cited: 158
Inflammasomes and Fibrosis
Wenjuan Zhang, Shujuan Chen, Shunchang Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 152
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
Dobromir Dobrev, Jordi Heijman, Roddy Hiram, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 3, pp. 145-167
Open Access | Times Cited: 150
Pulmonary fibrosis in the aftermath of the Covid-19 era (Review)
Eirini Vasarmidi, Eliza Tsitoura, Demetrios�� Spandidos, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 144
Post covid 19 pulmonary fibrosis. Is it real threat?
Deependra Kumar, Priya Sharma, Rahul Kumar
Indian Journal of Tuberculosis (2020) Vol. 68, Iss. 3, pp. 330-333
Open Access | Times Cited: 144
Signaling Pathways Involved in Diabetic Renal Fibrosis
Yuqing Zhang, De Jin, Xiaomin Kang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 141
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems
Valeria Visco, Carolina Vitale, Antonella Rispoli, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 524-524
Open Access | Times Cited: 100
PM2.5‐induced pulmonary inflammation via activating of the NLRP3/caspase‐1 signaling pathway
Hui Jia, Yang Liu, Dan Guo, et al.
Environmental Toxicology (2020) Vol. 36, Iss. 3, pp. 298-307
Open Access | Times Cited: 115
Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Lijun Zhao, Yutong Zou, Fang Liu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 113
High-Mobility Group Box 1 (HMGB1) and Autophagy in Acute Lung Injury (ALI): A Review
Lihua Qu, Chao Chen, Yangye Chen, et al.
Medical Science Monitor (2019) Vol. 25, pp. 1828-1837
Open Access | Times Cited: 101
Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT
Margherita Sisto, Doménico Ribatti, Sabrina Lisi
Biomolecules (2021) Vol. 11, Iss. 2, pp. 310-310
Open Access | Times Cited: 91
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial
Steven L. Brody, Sean P. Gunsten, Hannah Luehmann, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 1, pp. 78-89
Open Access | Times Cited: 87
Pirfenidone: A novel hypothetical treatment for COVID-19
Soroush Seifirad
Medical Hypotheses (2020) Vol. 144, pp. 110005-110005
Open Access | Times Cited: 83
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
Shahd Horie, Alistair Nichol, Emanuele Rezoagli, et al.
Intensive Care Medicine (2020) Vol. 46, Iss. 12, pp. 2265-2283
Open Access | Times Cited: 76
Pirfenidone modulates macrophage polarization and ameliorates radiation‐induced lung fibrosis by inhibiting the TGF‐β1/Smad3 pathway
Hangjie Ying, Min Fang, Qing Qing Hang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 18, pp. 8662-8675
Open Access | Times Cited: 76
Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation
Wenping Liu, Xiao Han, Qing Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113460-113460
Open Access | Times Cited: 42
Post-COVID-19 pulmonary fibrosis: An ongoing concern
Nuha Alrajhi
Annals of Thoracic Medicine (2023) Vol. 18, Iss. 4, pp. 173-181
Open Access | Times Cited: 34
SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation
Young-Sheng Chang, Bo-Han Ko, Jyh-Cherng Ju, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3179-3179
Open Access | Times Cited: 65
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm
Laura Artigas, Mireia Coma, Pedro Matos‐Filipe, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240149-e0240149
Open Access | Times Cited: 65
Pterostilbene prevents LPS-induced early pulmonary fibrosis by suppressing oxidative stress, inflammation and apoptosis in vivo
Huahong Yang, Hua Cong, Xiaolin Yang, et al.
Food & Function (2020) Vol. 11, Iss. 5, pp. 4471-4484
Closed Access | Times Cited: 64
Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A
Zhujie Cao, Ying Liu, Zhe Zhang, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 4, pp. 908-918
Open Access | Times Cited: 55
Emodin attenuates silica-induced lung injury by inhibition of inflammation, apoptosis and epithelial-mesenchymal transition
Xinru Pang, Linlin Shao, Xiaojuan Nie, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107277-107277
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top